All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

In Spain and in the rest of Western Europe, men who have sex with men (MSM) are the population most affected by HIV. Of the 1270 new HIV cases notified among MSM during 2016 39.4% were diagnosed at a late stage of infection (\< 350mm^3^ CD4 count at diagnosis) \[[@pone.0210637.ref001]\]. From a public health perspective, to promote earlier diagnosis and to reduce the undiagnosed fraction of the epidemic is one of the main priorities in HIV prevention programs worldwide because treatment reduces infectiousness and contributes to stop onward transmission \[[@pone.0210637.ref002], [@pone.0210637.ref003]\].

Recommendations for MSM are that an HIV test should be performed at least every 12 months and every 3 when having unprotected sex with casual partners \[[@pone.0210637.ref004]\]. However, studies across Europe point out that these recommendations are far from being met \[[@pone.0210637.ref005]--[@pone.0210637.ref008]\]. In fact, the first European men who have sex with men internet survey (EMIS) found that the percentage of untested MSM in western European countries ranged from 16.2% in France to 37.2% in Finland \[[@pone.0210637.ref009]\].

In Spain, HIV testing is offered free of cost at all levels of the public health system. It is also performed in a network of sexual health clinics and units that not only offer it free of cost but also anonymously. Confidential and anonymous rapid testing is also conducted for free by a number of community based organisations (CBO) and, in 5 regions, there are also pharmacy based rapid testing programmes where those who wish, can get tested by a pharmacist. In spite of the variety of settings, 26.1% of MSM in Spain have never been tested for HIV \[[@pone.0210637.ref010]\].

Barriers to testing include reasons related to risk perception, fear of stigma and discrimination and to health consequences derived from a positive result \[[@pone.0210637.ref011]\]. Additionally, there are also a number of structural barriers related to the characteristics of the diagnostic settings that include lack of anonymity and or/ confidentiality, having to wait, having to return to receive the result of a test, and the need to discuss sexual behaviours \[[@pone.0210637.ref011]\].

In this sense, self-testing is a methodology that could help to alleviate some of the aforementioned barriers. First approved in the US in 2012, self-testing has slowly but steadily spread across high-income countries. At present it is being marketed in the United Kingdom (UK), France, Belgium and Italy. In Spain self-testing kits started to be commercialized in January 2018 \[[@pone.0210637.ref012]\]. Self-testing provides individuals with the opportunity of learning their serostatus conveniently since it requires no appointments, no queues, no time invested in getting to testing sites and no pre and post-test discussion. On the other hand it also raises some concerns. The lack of face to face pre-test contact with a professional is one of the most common ones. Thus, it is important to provide good written and online materials to inform potential users both about the benefits and limitations (i.e window period and the need of a confirmation test) of self-testing. Coping with a positive self-test alone is another concern and support mechanisms need to be put into place to offer support and information for those in this situation. Finally there are also concerns about users who obtain a reactive self-test and do not seek confirmation testing and subsequent linkage to specialist care \[[@pone.0210637.ref013]--[@pone.0210637.ref016]\].

If self-testing is capable of eliminating some of the known barriers and of facilitating access to HIV testing among those who remain untested, it is crucial to know which subpopulations would use it. The literature assessing the impact that the introduction of self-testing could have in untested MSM is very limited and mostly comes from Australia and the US. In Europe, we found very few studies assessing this aspect in this population \[[@pone.0210637.ref017]--[@pone.0210637.ref019]\] and none of them focus on never tested individuals. Furthermore, we do not know what type of barriers self-testing would help to remove and what would happen in the case of receiving a positive result. Acts following a reactive self-test and preferences regarding confirmation sites remain unknown and are important elements that need to be taken into account for the future development of the strategy.

In the present paper we assess the impact that self-testing could have among untested MSM in Spain. We identify the subgroups that would benefit the most from its introduction and assess self-testing's capacity of overcoming barriers that deter people from testing. Additionally we also investigate several key aspects related to the testing process and linkage to care that need to be considered to assure an effective introduction of this methodology.

Methods {#sec006}
=======

Study participants {#sec007}
------------------

Inclusion criteria were being \> = 18 years of age and having reported lifetimes sex with other men. Of the 9489 participants who met the inclusion criteria and self-identified as HIV negative or had an unknown serostatus, we selected 2818 MSM who reported no previous HIV testing experience. Additionally, we excluded 229 who did not answer the main outcome variable (would have used self-testing if already available). Thus, 2589 participants were included in the final analysis. No incentives were given for participation.

Study procedures and measurements {#sec008}
---------------------------------

We conducted an internet based survey between September 2012 and April 2013. Our study was advertised mainly in gay dating websites operating in Spain. Details about the study procedures have been reported elsewhere \[[@pone.0210637.ref020]\]. Briefly, those who chose to access the survey website were directed to an informative screen. Here, participants learned about the purpose of the study and the estimated time to complete the questionnaire (15 min). They were also informed about the fact that no Internet Protocols or cookies were collected and that data was collected confidentially and anonymously. The questions were designed to elicit no identifying information. Thus, participants were asked to report their age in years rather than their date of birth. Likewise, we did not include questions on the city or town of residence; instead, we asked only about the approximate number of inhabitants. Given the online nature of the study, written consent was obtained by an "I agree to participate" button which was presented to participants at the end of the informative screen. Once they clicked, they accessed the questionnaire. The study and all its materials (including the questionnaire) were approved by the Carlos III health institute ethical committee (CEI PI 70_2015). All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Study did not include minors.

The questionnaire was designed in Spanish and collected data on socio-demography, lifestyle, sexual behaviours, testing history and several aspects related to HIV self-testing. The main outcome for this analysis was intention to use self-testing which was assessed with the question "Would you have used a self-test for HIV, had it been available in pharmacies in Spain?". Replies initially were set as "yes", "probably yes", "not sure", "probably no", "no" and were transformed into a binary variable for analysis: "yes/probably yes" and "I am not sure/probably no/no".

To assess the barriers of access to HIV testing we used a question with eleven closed response options and one open-ended. Participants were asked to choose their single most important reason. For the analysis, they were recoded into a four-category variable, as follows:

A.  Low perceived risk for HIV, which included the options: "I found myself very healthy", "I thought that with my behaviours I could not be infected".

B.  Fears of testing positive, which included: "Fear of the consequences for my health", "Fear of not being able to get / lose my job", "Fear of not being able to get/lose a residence permit", "Fear of rejection or discrimination".

C.  Structural barriers, including the options: "I didn\'t want to go to my GP/health center", "Concerns arising from the loss of anonymity while being tested", "I knew I had to wait several days to get the results", "I wanted to do it in a private centre but had no money", "Feel discomfort answering intimate questions"

D.  "Other reason": To allow participants to express another reason not listed among the aforementioned.

The questions of the survey used for this analysis can be found as supporting information ([S1 Appendix](#pone.0210637.s001){ref-type="supplementary-material"}).

Statistical analysis {#sec009}
--------------------

First, we performed a descriptive analysis of the main characteristics of never tested MSM.

Second, we calculated the proportion of participants that reported having intentions of using a self-test if already available and cross-tabulated our data by relevant sociodemographic and behavioral variables as well as by type of self-reported barrier for testing.

To address associations between intention to use self-testing and MSM characteristics, we calculated crude and adjusted prevalence ratios (PRs) and their corresponding 95% confidence intervals (CIs). We chose to use poisson regression with robust variance because it is a better alternative than logistic regression in cross-sectional studies with frequent outcomes \[[@pone.0210637.ref021], [@pone.0210637.ref022]\]. All the statistically significant factors at p\<0.2 in the single variable analysis were introduced a multivariable regression model. We used the minimum Akaike information criteria (AIC) values to perform model comparisons and select the optimal model. Respondents with missing data on \> = 1 variables of the multivariable model, were not included in the regression model.

We performed the analysis using STATA 11 software (StataCorp, Texas, United States, United States).

A third level of analysis, focused on those who reported intention to use a self-test. In this group, we assessed the preference towards self-testing among all testing options, the type of self-test preferred (blood/oral) and whether they would use it alone or accompanied by someone. We also assessed the number of times they would have used a self-test, in what way they would incorporate it to their usual testing pattern, and what would be their preferred setting to seek for a confirmation test if the self-test was reactive. This analysis has been stratified by the type of barrier self-reported by participants and the relationship between the categorical variables was assessed using Pearson's Chi-square test. Statistical significance was defined as a two-tailed p value of less than 0.05.

Results {#sec010}
=======

Some 91.8% of all participants were born in Spain, 44.8% were 30 years of age or older and 46.7% had finished a university degree. In the preceding 12 months, most had lived in Spain (96.0%) in a city of more \> = 100.000 inhabitants (58.1%). Additionally, 41.3% reported having had sex with men and women, 20.3% had kept their sex life with other men in total secrecy and 60.2% were not related to the gay scene ([Table 1](#pone.0210637.t001){ref-type="table"}).

10.1371/journal.pone.0210637.t001

###### Prevalence and factors associated with intention to use self-testing if already available among never tested MSM in Spain (N = 2,589[^a^](#t001fn002){ref-type="table-fn"}).

![](pone.0210637.t001){#pone.0210637.t001g}

                                                                                Total (N = 2589)   Participants with intentions to use self-testing (N = 2161)                                                                     
  ----------------------------------------------------------------------------- ------------------ ------------------------------------------------------------- ------ ------- ---------- ---------------- ----------- ---------- ----------------
  **Age**                                                                                                                                                                                                                          
      \<30 years old                                                            1428               55.2                                                          1160   81.2    1.00                                    1.00       
      ≥30 years old                                                             1158               44.8                                                          998    86.2    **1.06**   **1.03--1.10**   **0.001**   **1.05**   **1.01--1.10**
  **Education level**                                                                                                                                                                                                              
      \<University                                                              1376               53.3                                                          1159   84.2                                                       
      ≥University                                                               1206               46.7                                                          997    82.7    0.98       0.95--1.02       0.288                  
  **Place of recidence**[^**b**^](#t001fn003){ref-type="table-fn"}                                                                                                                                                                 
      Latin-America                                                             23                 1.0                                                           21     91.3    1.00                                    1.00       
      Other European country                                                    64                 2.7                                                           50     78.1    0.86       0.71--1.03       0.091       0.86       0.70--1.05
      Spain                                                                     2310               96.0                                                          1938   83.9    0.92       0.81--1.04       0.193       0.93       0.79--1.08
      Other Country                                                             10                 0.4                                                           10     100.0   1.01       0.97--1.24       0.158       1.13       0.95--1.34
  **Settlement size (inhabitants)**[^**b**^](#t001fn003){ref-type="table-fn"}                                                                                                                                                      
      \>100,000                                                                 1389               58.1                                                          1156   83.2    1.00                                    1.00       
      \<100,000 (within 30 km of a big city)                                    619                25.9                                                          518    83.7    1.01       0.96--1.05       0.798       1.01       0.97--1.05
      \<100,000 (\> = 30 km of a big city)                                      383                16.0                                                          330    86.2    1.04       0.99--1.09       0.145       1.01       0.97--1.06
  **Cohabitation**[^**b**^](#t001fn003){ref-type="table-fn"}                                                                                                                                                                       
      Lives alone                                                               830                34.7                                                          712    85.8    1.00                                    1.00       
      Lives with sexual partner                                                 484                20.2                                                          418    86.4    1.01       0.96--1.05       0.769       0.99       0.95--1.04
      Lives with others (not a sexual partner)                                  1081               45.1                                                          880    81.4    **0.95**   **0.91--0.99**   **0.010**   0.98       0.94--1.02
  **Sexual partners (lifetime)**                                                                                                                                                                                                   
      Men & women                                                               1070               41.3                                                          898    83.9    1.00                                               
      Men only                                                                  1519               58.7                                                          1263   83.1    0.99       0.96--1.03       0.598                  
  **Disclosure of sexual orientation**                                                                                                                                                                                             
      Has not disclosed his sexual orientation                                  492                20.3                                                          403    81.9    1.00                                    1.00       
      Has disclosed his sexual orientation to someone                           1937               79.7                                                          1639   84.6    1.03       0.99--1.08       0.163       1.03       0.98--1.08
  **Relation with gay culture**                                                                                                                                                                                                    
      Member of a gay CBO[^c^](#t001fn004){ref-type="table-fn"}                 59                 2.5                                                           42     71.2    1.00                                    1.00       
      Not member of gay CBO but frequents the gay scene                         875                37.3                                                          755    86.3    **1.21**   **1.03--1.43**   **0.022**   1.08       0.93--1.27
      Not related to gay scene                                                  1410               60.2                                                          1176   83.4    1.17       0.99--1.38       0.058       1.06       0.90--1.23
  **Anal intercourse & condom use**[^**b**^](#t001fn003){ref-type="table-fn"}                                                                                                                                                      
      No anal intercourse                                                       129                5.3                                                           86     66.7    1.00                                    1.00       
      Had, but all were protected[^d^](#t001fn005){ref-type="table-fn"}         937                38.7                                                          759    81.0    **1.22**   **1.07--1.38**   **0.002**   **1.15**   **1.02--1.30**
      Had unprotected anal intercourse                                          1357               56.0                                                          1190   87.7    **1.32**   **1.16--1.49**   **0.001**   **1.21**   **1.07--1.37**
  **Has been paid for sex**                                                                                                                                                                                                        
      Yes                                                                       99                 4.1                                                           84     84.8    1.00                                               
      No                                                                        2340               95.9                                                          1963   83.9    0.99       0.91--1.08       0.793                  
  **Has paid for sex**                                                                                                                                                                                                             
      Yes                                                                       176                7.2                                                           150    85.2    1.00                                               
      No                                                                        2266               92.8                                                          1900   83.8    0.98       0.92--1.05       0.618                  
  **Injection drug use**                                                        2442                                                                                                                                               
      Never                                                                     2384               98.9                                                          2002   84.0    1.00                                               
      Yes, \> = 12 months ago                                                   15                 0.6                                                           11     73.3    0.87       0.64--1.19       0.385                  
      Yes, in the last 12 months                                                12                 0.5                                                           10     83.3    0.99       0.77--1.28       0.953                  
  **History of STIs**                                                                                                                                                                                                              
      No                                                                        1798               74.9                                                          1491   82.9    1.00                                    1.00       
      Lifetime diagnosis of STI                                                 603                25.1                                                          523    86.7    **1.05**   **1.01--1.09**   **0.018**   0.99       0.96--1.03
  **Main reason for not HIV testing**                                                                                                                                                                                              
      Low perceived risk for HIV                                                1236               48.2                                                          936    75.7    1.00                                    1.00       
      Fear of testing positive                                                  229                8.9                                                           193    84.3    **1.11**   **1.04--1.19**   **0.001**   **1.12**   **1.05--1.20**
      Structural barriers                                                       931                36.3                                                          884    94.9    **1.25**   **1.21--1.30**   **0.000**   **1.23**   **1.19--1.28**
      Other                                                                     166                6.5                                                           122    73.5    0.97       0.88--1.07       0.544       0.98       0.89--1.08

cPR: crude prevalence ratio; aPR: adjusted prevalence ratio; CI: confidence interval

^a^ Due to missing data the numbers might not add up to totals

^b^ In the last 12 months

^c^ Community-Based Organization

^d^ Protection referred to condom use only

More than half (56.0%) had had at least one unprotected anal intercourse (UAI) in the last 12 months, 7.2% had ever paid for sex, 4.1% had ever been paid for sex and 25.1% reported having been diagnosed with a sexually transmitted infection (STI). Very few (1,1%) had ever injected drugs ([Table 1](#pone.0210637.t001){ref-type="table"}).

Regarding the reasons for never having been tested before, 48.2% of the participants reported low perceived risk which included the following reasons "I thought that with my behaviors I could not be infected "(37.3%) and "I found myself very healthy" (10.5%). Structural barriers were reported by 36.4% and included: "Concerns arising from the loss of anonymity" (16.5%), "Feeling discomfort answering intimate questions" (8.3%), "I didn\'t want to go to my GP/health center" (7.7%), "I knew I had to wait several days to get the results" (1.9%), "I wanted to do it in a private center but had no money" (1.5%). Fears derived from testing positive were reported by 8.9% of the participants and included "Fear of the consequences for my health" (6.1%),"Fear of rejection or discrimination" (2.1%), "Fear of not being able to get/lose work" (0.5%) and "Fear of not being able to get/lose residence permit" (0.1%). The remaining 6.4% of the participants reported "other reasons".

The overall proportion of participants who reported intentions of using a self-test if already available, was of 83.5% (95%CI: 82.0--84.9): 53.3% answered "yes" and 30.2% "probably yes".

The results of the poisson regression analysis to assess the association of lifestyle and behavioral characteristics with the intention to use self-testing are shown in [Table 1](#pone.0210637.t001){ref-type="table"}. In the multivariate model, variables that remained significantly associated with intention to use self-testing were age of \> = 30 years (PR, 95%CI: 1.05, 1.01--1.10), having had anal intercourse in the last twelve months either protected or not (PR, 95%CI: 1.15, 1.02--1.30; PR, 95%CI: 1.21, 1.07--1.37; respectively), reporting fears derived of testing positive (PR, 95%CI: 1.12, 1.05--1.20) and structural barriers to get tested for HIV (PR, 95%CI: 1.23, 1.19--1.28 ([Table 1](#pone.0210637.t001){ref-type="table"}). The proportion of missing data of the independent variables are included as supplementary material ([S1 Table](#pone.0210637.s002){ref-type="supplementary-material"})

The proportion of participants that identified self-testing as their preferred testing option was of 78.3% and was higher among those who reported structural barriers (83.8%) than among those who were never testers because of low risk perception (74.5%) or fear related reasons (71.0%) (p\<0.001). Almost half (45.9%) reported that they would be willing to use any of the two self-testing options (blood or saliva) and 84.5% that they would prefer to use it alone instead of with someone ([Table 2](#pone.0210637.t002){ref-type="table"}).

10.1371/journal.pone.0210637.t002

###### Type of self-test preferred, aspects of the HIV self-testing process and potential use by type of barrier reported by those who expressed intention to use self-testing if already available.

![](pone.0210637.t002){#pone.0210637.t002g}

                                                                                                         Type of barrier                                                      
  ------------------------------------------------------------------------------------------------------ ----------------- ------ ----- ------ ----- --------- ------ ------- ---------
  ***N*, *% (row)***                                                                                     936               46.5   193   9.6    884   43.9      2013   100.0   
  **Refers self-testing as the preferred testing option**                                                697               74.5   137   71.0   741   83.8      1575   78.3    \<0.001
  **Type of self-test preferred**                                                                                                                                             0.60
      Blood                                                                                              128               13.9   30    15.9   129   14.8      287    14.5    
      Saliva                                                                                             383               41.5   71    37.6   331   38.0      785    39.6    
      Either                                                                                             412               44.6   88    46.6   411   47.2      911    45.9    
  **How would you prefer to use a self-test kit?**                                                                                                                            0.64
      Alone                                                                                              785               84.7   157   82.2   742   84.9      1684   84.5    
      Acompanied by someone                                                                              142               15.3   34    17.8   132   15.1      308    15.5    
  **Times a self-test would have been used if already available**                                                                                    \<0.001                  
      Only once                                                                                          482               51.8   56    29.0   317   36.2      855    42.8    
      Two to trhee times                                                                                 357               38.3   100   51.8   403   46.0      860    43.0    
      Four or more times                                                                                 92                9.9    37    19.2   156   17.8      285    14.2    
  **Frequency of use if self-test kits were available**                                                                                                                       0.013
      I would never/rarely use it, I rather get tested by a trained professional                         129               14.3   30    16.1   93    10.9      252    13.0    
      It would be my usual testing method, although I would also seek testing by trained professionals   293               32.4   54    29.0   240   28.2      587    30.2    
      I would always use it                                                                              482               53.3   102   54.8   519   60.9      1103   56.8    
  **Reaction following a positive self-test**                                                                                                                                 \<0.001
      Not sure what would I do                                                                           89                9.6    49    25.5   122   14.0      260    13.0    
      I would self-test again before taking a decision                                                   132               14.2   27    14.1   146   16.7      305    15.3    
      I would seek for confirmation in a sexual health clinic                                            276               29.6   53    27.6   264   30.2      593    29.7    
      I would seek for confirmation in primary care                                                      316               33.9   42    21.9   241   27.6      599    30.0    
      I would seek for confirmation in a private laboratory                                              62                6.7    10    5.2    54    6.2       126    6.3     
      I would seek for confirmation in a CBO/NGO                                                         39                3.1    8     4.2    29    3.3       66     3.3     
      I would seek for confirmation in a family planning service, pharmacy or others                     27                2.9    3     1.6    18    2.1       48     2.4     

Participants who reported fear and structural related barriers tended to think they would have used it more times (p\<0.001) than those who reported low risk perception or fear. If approved, self-testing would always be used by 56.8% of the participants and those who reported structural barriers chose this option more frequently (60.9%) than the other two groups (p = 0.013) ([Table 2](#pone.0210637.t002){ref-type="table"}).

In the case of receiving a positive result, the preferred confirmation sites would be primary care (30.0%) and sexual health clinics (29.7%), although a substantial percentage of MSM with fear related barriers (25.2%) reported not being sure of what would they do (p\<0.001) ([Table 2](#pone.0210637.t002){ref-type="table"}).

Discussion {#sec011}
==========

A large majority of the untested MSM we recruited online reported that they would have used an HIV self-test if already available. Intention to use was especially high among older MSM who reported anal intercourse in the las 12 months and among those who reported barriers to testing not related to risk perception. Among those who expressed willingness to self-test, a large majority identified it as their preferred mode of testing and reported that, if available, they would use this method exclusively. Most would attend primary care and sexual health clinics for confirmatory purposes although a quarter of those expressing fear of the consequences of a positive result are not sure of what would they do if they obtained a positive result.

The percentage of untested MSM was slightly higher than that reported by a Spanish study that also analyzed MSM recruited online (26%) \[[@pone.0210637.ref010]\]. We found three European studies that assessed the willingness of MSM to use HIV self-testing kits \[[@pone.0210637.ref017]--[@pone.0210637.ref019]\] and proportions ranged from 54.6% \[[@pone.0210637.ref019]\] to figures of nearly 90% and, therefore, very similar to our results \[[@pone.0210637.ref017], [@pone.0210637.ref018]\]. Of these studies, only two assessed the association between testing history and willingness to use a self-test kit \[[@pone.0210637.ref018], [@pone.0210637.ref019]\] and they present conflicting results. Whereas in the study by Greacen et al. having never tested before was associated with interest in accessing an HIV test, in the study by Rosales et al. it was the opposite and those with previous testing experience were the ones that reported higher levels of interest in purchasing a self-test. Nevertheless, both of them include testing history as an independent variable making it impossible to assess which particular sub-groups of never testers would benefit from its approval. As far as we know, the present paper represents the first study at a European level that tries to distinguish which groups of never-testers would use it if approved.

In this sense, the fact that older age is associated with willingness to use a self-test is an important issue as they are more affected by late diagnosis in Spain \[[@pone.0210637.ref001]\] and elsewhere in Europe \[[@pone.0210637.ref023]\]. It also means that it would benefit never tested MSM with longer periods at risk of HIV acquisition and, hence, a subgroup with higher number of unknown infections as suggested in several studies \[[@pone.0210637.ref024], [@pone.0210637.ref025]\]. The fact that participants involved in UAI in the last 12 months were the ones who reported higher willingness of using a self-test kit stresses the potential of self-testing as a tool that could play an important role on promoting testing among a hard to reach population who is not using pre-existing testing options in spite of being at risk of acquiring HIV.

A key factor that has not been assessed until now is what type of barriers HIV self-testing would help to remove. Populations with different barriers will be in the need of different testing strategies. In this sense, according to our results, the group less benefited by the approval of HIV self-testing kits would be those MSM that reported low risk perception. Low risk perception affects the intention of actively seeking an HIV test and those reporting it could probably be better targeted by provider initiated strategies \[[@pone.0210637.ref026]\] and tailored interventions to increase their risk perception.

Self-testing kits might be better fit for those who are not willing to access existing services due to structural barriers or because of fears derived from a potential positive result. This is in line with our results. Those facing structural barriers are a relevant group in size in our sample and represent almost 4 in 10 of the untested MSM. In Spain, where testing services are provided in a large variety of contexts, structural barriers could have to do more with the acceptability rather than with the availability of services. In this sense, some characteristics of self-testing such as complete anonymity, not having to deal with the anxiety of long periods of wait for the test results, convenience, or not having to discuss one's sex life with a health provider, might be some of the reasons that make this testing option such a valued option for untested MSM who reported structural barriers. Never tested participants affected by barriers related to fears derived from a positive result are a much smaller group in size but would also benefit greatly from the introduction of self-testing kits.

According to our results, self-testing could become a very popular option among untested MSM. Most participants reported that it would become their favorite testing option and more than half said that they would only use this option. This however represents a major challenge: providing HIV confirmation testing and linkage to care services for all those who obtain a positive self-test. In this sense, further studies should be carried out to monitor confirmation testing and linkage to care among individuals receiving a positive self-test as data on the subject are extremely scarce at the moment \[[@pone.0210637.ref027], [@pone.0210637.ref028]\]. Most of our participants reported that they would seek for confirmation in the case of obtaining a positive self-test but, especially among those who faced fear related barriers, there is a substantial group that reported not being sure of what they would do in this scenario. It is important to ensure that in the case of obtaining a positive result a confirmatory test is performed within a time period that allows fulfilling the requirements of optimal linkage to care.

Several limitations need to be considered when interpreting these results. Although it is true that online dating websites are an increasingly frequent way of socializing and meeting new sex partners, the generalisation of these results to the overall untested MSM population needs to be made with caution. The data analysed in this paper, was collected immediately after the approval of self-testing in the US. Since then, self-testing has also been approved and legalised in several other European countries. MSM could have become more knowledgeable about it and some current opinions could be different to those from back in 2012--2013. Additionally, we do not know how answers based on the hypothetical situation of self-testing already being marketed, can translate into actual use. Those who expressed intentions of using it, could be reflecting a preference or sympathy towards this option. This however, does not mean it would necessarily lead to the purchase and use of a self-test kit when made available.

The proportion of missing values among those who reported medium or low testing intentions tended to be slightly higher than among those with high testing intentions ([S1 Table](#pone.0210637.s002){ref-type="supplementary-material"}). This needs to be taken into account when interpreting the results as it could be leading to an overestimation of those reporting high testing intentions. Nevertheless, its influence should be minimal given that the proportion of missing data is always under the 10% mark (0.1%- 9.5%). The difference of missing value rates should not change the interpretation of the results of our main outcome variable which is very frequent (83.5%).

The high acceptability of this testing method underlines its capacity of being a potentially relevant tool to promote testing among a severely undertested population. It would especially benefit subpopulations of older age, that have been involved in unprotected anal sex and that do not want to access already existing services due to structural barriers or because of fear derived from a positive result. Its high potential impact also represents a major challenge to ensure clear confirmation pathways to enable swift and effective linkage to care for those who obtain a positive self-test result.
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